AbbVie invests €40 million to expand medical device facility in Sligo, Ireland

Specifications:

Name:

AbbVie invests €40 million to expand medical device facility in Sligo, Ireland

Location:

Sligo, Ireland

Company:

AbbVie

Estimated Cost:

€40 million

Source:

www.abbvie.mediaroom.com

Introduction:

AbbVie, a global biopharmaceutical company plans to €40 million to expand its medical device manufacturing facility in Ballytivnan, Sligo, Ireland.

Features:

This Investment is over the next four years, which creates 50 new highly-skilled jobs focused on devices that deliver AbbVie’s medicines to patients around the world. The investment is supported by the Industrial Development Authority (IDA) of Ireland and was announced today at an event attended by the Minister for Jobs, Enterprise and Employment, Richard Bruton, TD.

The company’s manufacturing site in Ballytivnan currently produces drug delivery devices, including a pen-style injector that is used by patients around the world who use AbbVie’s treatment indicated for a range of auto-immune conditions. The site is AbbVie’s ‘centre of excellence’ for medical device manufacture, precision engineering, plastics moulding and metrology.

AbbVie’s development of a global medical device centre of excellence in Sligo is broadening the potential for the company’s local workforce. For example, AbbVie is partnering with the Institute of Technology, Sligo, which is establishing a new medical device-focused education program on its Sligo campus.